ABSTRACT
Objectives Fatigue is a pervasive clinical symptom for many infected with an influenza virus. Prior evidence from influenza pandemics suggest that fatigue symptomology may continue beyond the acute phase, lasting for several months to several years post-discharge. This living systematic review aimed to examine long-term fatigue prevalence among survivors and among communities, as well as investigate the current evidence for associated factors.
Design Systematic review and meta-analysis.
Setting Hospitalised and community samples.
Participants Patient populations with a confirmed diagnosis of a named influenza virus.
Main outcomes measured Fatigue, fatigue syndromes
Results Ten studies met the inclusion criteria for a pooled prevalence analysis and five studies were identified as eligible for a means differences analysis. A fatigue prevalence of 41% (95% CI 0.299-0.488) was found among a total population of 1,310. Using the ‘vitality’ subscale of the SF-36 as a proxy for fatigue, the estimate for means differences indicated a lower mean vitality score for survivors compared to population norms (M −1.523, CI −13.53 – 10.48), although this was not significant (p = 0.803). The most common associations with fatigue were PTSD, depression and anxiety, ICU admission, female gender and higher age.
Conclusions This study reveals that a significant proportion of survivors (41%) experienced fatigue following their recovery from an influenza virus such as SARS or MERS and that this fatigue can be long-lasting. Also, that some factors such as female gender and psychological factors may contribute to continuing fatigue outcomes for this population.
Strengths and limitations (a) this study provides support for long-term fatigue outcomes in people with a confirmed coronavirus or other influenza virus pandemic, (b) the study suggests an aetiological role for some psychological and social factors, (c) findings are limited by the availability of fatigue data and lack of pre-morbid fatigue information; (d) a meta-analysis on the associations was prohibited by the small number of studies investigating long-term fatigue correlates and (e) the heterogeneity of the studies (>75%) suggests the pooled estimates should be interpreted with caution.
- fatigue
- chronic fatigue
- survivors
- pandemic
- long-term
- coronavirus
- living review
Competing Interest Statement
Authors have completed the ICMJE uniform disclosure at www.icmje.org/coi_disclosure.pdf and declare no support from any organisation for the submitted work. TC is the author of several self-help books on chronic fatigue for which she has received royalties. TC (KCL) has received ad hoc payments for workshops carried out in long-term conditions. KCL have received payments for TC's editor role in the Journal of Mental Health. TC acknowledges financial support from NIHR, Health Technology Assessment, Guys &St Thomas Charity, Muscle Disease UK. She has a patent background IP with a software company. No fees received to date; no other relationships or activities that could appear to have influenced submitted work.
Funding Statement
This research received no specific grant from any funding agency, commercial or not-for-profit sectors. TC receives salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed in this article are those of the authors and not necessarily those of the NIHR or the NHS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.